Skip to main content

Table 1 Basic and clinical data of RIPC and control patients

From: Activities of cardiac tissue matrix metalloproteinases 2 and 9 are reduced by remote ischemic preconditioning in cardiosurgical patients with cardiopulmonary bypass

Variable

Control (N = 17)

RIPC (N = 18)

P-value

Demographic data

   

Male (N)

17 (100%)

14 (77.8%)

0.10

Female (N)

0 (0%)

4 (22.2%)

0.10

Age (years)

63 ± 9

68 ± 11

0.03

Weight (kg)

86 ± 9.5

80 ± 11

0.04

BMI (kg/m2)

28 ± 3.2

26 ± 3.6

0.04

Type of surgery

   

CABG (N)

9 (52.9%)

13 (72.2%)

0.31

AVR (N)

2 (11.8%)

2 (11.1%)

1.00

Combi (N)

6 (35.3%)

3 (16.7%)

0.26

Perioperative data

   

Bypass time (min)

128 ± 34

108 ± 51

0.01

Aortic clamping time (min)

86 ± 25

70 ± 36

0.01

EuroSCORE

3 ± 2

4 ± 2

0.03

  1. AVR, aortic valve replacement; BMI, body mass index; CABG, coronary artery bypass graft; Combi, combined surgery.